Avanos Medical (AVNS) Shares Outstanding (2013 - 2026)

Avanos Medical has disclosed Shares Outstanding (Entity) across 14 years of filings, most recently posting $46.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 0.94% year-over-year to $46.7 million; the TTM figure through Mar 2026 stood at $46.7 million (up 0.94% YoY), while the FY2025 annual figure was $46.5 million, up 1.07% from the prior year.
• Shares Outstanding (Entity) came in at $46.7 million for Q1 2026 at Avanos Medical, roughly flat from $46.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $47.3 million in Q1 2022 to a low of $45.9 million in Q2 2024.
• Average Shares Outstanding (Entity) over 5 years is $46.4 million, with a median of $46.4 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) decreased 3.48% in 2022 and grew 1.07% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $46.5 million in 2022, then fell by 0.76% to $46.2 million in 2023, then retreated by 0.46% to $46.0 million in 2024, then climbed by 1.07% to $46.5 million in 2025, then gained by 0.47% to $46.7 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $46.7 million in Q1 2026, $46.5 million in Q4 2025, and $46.4 million in Q3 2025.